CBL vs IMM

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

CBL

CTRLBIONIC FPO [CBL]

50MEDIUM

IMM

IMMUTEP FPO [IMM]

61MEDIUM-HIGH

Score Breakdown

CBL IMM
Technical
51
42
Catalyst
51
50
Sentiment
50
50
Fundamental
30
92
Momentum
59
50
Risk Gate
50
42

Key Metrics

CBL Metric IMM
$33.7MMarket Cap$72.2M
1.0MAvg Volume (20d)4.5M
N/AShort Interest+2.2%
$0.09552-Week High$0.470
$0.03252-Week Low$0.028
+6.9%Daily Change-4.1%
$0.062Reference Price$0.047
-122.9%ROE-77.3%
-134.5%Profit MarginN/A

Active Signals

CBL Signals

●MACD momentum is picking up steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.4 quarters)
●Moderate P/S ratio (6.2x)
●Revenue in sharp decline (-38%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

IMM Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 6.0% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (5 quarters)

Ask Scout AI to compare CBL and IMM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs CMP →DOC vs IIQ →DOC vs LDX →DOC vs SPL →IIQ vs SOM →
CBL Full Analysis → IMM Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).